Get started
Author

René Zieglmayer

Observed names: - Rene Zieglmayer, R Zieglmayer, R. Zieglmayer, Ren?? Zieglmayer, Rene Zieglmayer, Zieglmayer René
OpenAlex ID: A5108471288
Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber
2009 · Friedrich Horak, Petra Zieglmayer, et al. · Journal of Allergy and Clinical Immunology · 173
PDF
Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber
2015 · Hendrik Nolte, Jennifer Maloney, et al. · Journal of Allergy and Clinical Immunology · 160
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
2016 · Petra Zieglmayer, Margarete Focke-Tejkl, et al. · EBioMedicine · 140
PDF
Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen–induced allergic rhinitis in an allergen-exposure unit
2002 · Friedrich Horak, Ursula P. Stübner, et al. · Journal of Allergy and Clinical Immunology · 111
Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy
2005 · Friedrich Horak, Ursula Petra Zieglmayer, et al. · Current Medical Research and Opinion · 98
The CRTH 2 antagonist OC 000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo‐controlled, double‐blind trial
2012 · F. Horak, P. Zieglmayer, et al. · Allergy · 85
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber
2009 · Friedrich Horak, Petra Zieglmayer, et al. · Inflammation Research · 84
Selection of house dust mite–allergic patients by molecular diagnosis may enhance success of specific immunotherapy
2018 · Kuan-Wei Chen, Petra Zieglmayer, et al. · Journal of Allergy and Clinical Immunology · 79
Pru p 3, a marker allergen for lipid transfer protein sensitization also in Central Europe
2017 · N. Mothes‐Luksch, M. Raith, et al. · Allergy · 76
PDF
Controlled Comparison of the Efficacy and Safety of Cetirizine 10 mg o.d. and Fexofenadine 120 mg o.d. in Reducing Symptoms of Seasonal Allergic Rhinitis
2001 · F. Horak, P. Stübner, et al. · International Archives of Allergy and Immunology · 66
A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber
2009 · Friedrich Horak, Petra Zieglmayer, et al. · Annals of Allergy Asthma & Immunology · 63
A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit – the Vienna Challenge Chamber (VCC)
2004 · P. Stübner, R. Zieglmayer, et al. · Current Medical Research and Opinion · 63
Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy
2011 · L. Van Overtvelt, V. Baron-Bodo, et al. · Allergy · 55
Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber
2006 · Petra Stuebner, Friedrich Horak, et al. · Annals of Allergy Asthma & Immunology · 52
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration
2005 · Friedrich Horak, Petra U. Zieglmayer, et al. · British Journal of Clinical Pharmacology · 52
PDF
Underestimation of house dust mite–specific IgE with extract-based ImmunoCAPs compared with molecular ImmunoCAPs
2018 · Huey-Jy Huang, Yvonne Resch-Marat, et al. · Journal of Allergy and Clinical Immunology · 47
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report
2021 · Oliver Pfaar, Karl‐Christian Bergmann, et al. · Allergy · 41
PDF
The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis
2013 · Philippe Bareille, Robert D. Murdoch, et al. · International Journal of Clinical Pharmacology and Therapeutics · 41
Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen
2016 · Yvonne Resch, Katharina Blatt, et al. · PLoS ONE · 40
PDF
IgE recognition of the house dust mite allergen Der p 37 is associated with asthma
2021 · Huey-Jy Huang, Yvonne Resch-Marat, et al. · Journal of Allergy and Clinical Immunology · 38
Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis
2016 · Friedrich Horak, Kamal D. Puri, et al. · Journal of Allergy and Clinical Immunology · 35
PDF
Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber
2008 · Petra Zieglmayer, René Zieglmayer, et al. · Current Medical Research and Opinion · 35
Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial
2016 · Petra Zieglmayer, Hendrik Nolte, et al. · Annals of Allergy Asthma & Immunology · 32
Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study
2018 · Franziska Roth-Walter, René Schmutz, et al. · World Allergy Organization Journal · 25
Expression in Escherichia coli and Purification of Folded rDer p 20, the Arginine Kinase From Dermatophagoides pteronyssinus: A Possible Biomarker for Allergic Asthma
2020 · Eszter Sarzsinszky, Christian Lupinek, et al. · Allergy Asthma and Immunology Research · 23
Works count: 55
Citation count: 1,899
H-index: 24
I10-index: 31
Year
Topic
Type